NTHI

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) is an early-stage biotechnology company founded in 2023 and headquartered in Los Angeles, California. The company went public in March 2025 through an initial public offering. Neonc focuses on developing innovative molecular technologies designed to enhance the targeted delivery of therapeutic agents for treating central nervous system diseases, particularly brain cancers. As a clinical-stage biotech company, Neonc is currently advancing its lead drug candidates through various phases of clinical trials while burning through cash to fund research and development activities.